Core Laboratories (NYSE:CLB) Hits New 1-Year High – Should You Buy?

Core Laboratories Inc. (NYSE:CLB)’s stock price hit a new 52-week high during trading on Friday . The stock traded as high as $20.36 and last traded at $20.0010, with a volume of 12153 shares changing hands. The stock had previously closed at $19.63.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Trading Up 1.6%

The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 2.37. The company has a market capitalization of $928.64 million, a P/E ratio of 29.78, a PEG ratio of 17.04 and a beta of 1.03. The company’s fifty day simple moving average is $16.79 and its 200-day simple moving average is $13.94.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, October 22nd. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.03. The company had revenue of $134.52 million for the quarter, compared to analyst estimates of $130.92 million. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. Core Laboratories’s revenue was up .1% compared to the same quarter last year. During the same period last year, the company posted $0.25 earnings per share. Research analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Hedge Funds Weigh In On Core Laboratories

Institutional investors and hedge funds have recently bought and sold shares of the company. Ariel Investments LLC lifted its holdings in shares of Core Laboratories by 25.5% during the 2nd quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company’s stock valued at $149,489,000 after purchasing an additional 2,634,438 shares during the last quarter. CWA Asset Management Group LLC acquired a new position in Core Laboratories during the 4th quarter valued at about $9,978,000. Disciplined Growth Investors Inc. MN increased its position in Core Laboratories by 9.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after buying an additional 528,976 shares in the last quarter. Gendell Jeffrey L raised its stake in Core Laboratories by 24.6% in the second quarter. Gendell Jeffrey L now owns 569,471 shares of the oil and gas company’s stock valued at $6,560,000 after buying an additional 112,475 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in Core Laboratories by 48.1% in the third quarter. Bank of America Corp DE now owns 343,340 shares of the oil and gas company’s stock worth $4,244,000 after acquiring an additional 111,527 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.